BWX Technologies (BWXT) Investor presentation summary

Strategic positioning and market drivers

• Focus on nuclear solutions for global security, clean energy, environmental restoration, medicine, and space exploration, with a strong commitment to innovation and operational excellence.

• Estimated 2026 revenue of ~$3.75B and backlog of $7.3B as of December 2025, supported by ~10,400 employees.

• Investment thesis centers on scale, differentiation, secular demand in government and commercial markets, disciplined capital allocation, and a pathway to mid- to high-single-digit EBITDA and double-digit free cash flow growth.

• Decades of nuclear operations experience, world-class manufacturing, and unique NRC Category 1 licenses underpin a strong market position.

• High barriers to entry, long-term visibility, and limited GDP cyclicality create favorable business characteristics and pricing power.

Growth opportunities and secular trends

• National security and energy independence drive demand, with 30+ years of visibility into U.S. Navy shipbuilding and ~$50B annual funding to U.S. government-related programs.

• Microreactors and SMRs address military, remote, and decarbonization needs; nuclear is positioned as the only baseload green technology.

• Medical radioisotope market expected to exceed $30B by 2030, with over 100 radiopharmaceuticals in the pipeline.

• Canadian commercial nuclear market benefits from recurring aftermarket services, refurbishment, and new build opportunities, with a projected $2B annual market.

• SMR market gaining traction with significant government support and commitments for deployments in North America and Europe.

Segment performance and financial outlook

• Government Operations: 2026 revenue guidance of $2.35B, targeting mid-single-digit adjusted EBITDA growth, driven by special materials and naval propulsion.

• Commercial Operations: 2026 revenue guidance of $1.4B, with ~25% growth expected from organic expansion and the Kinectrics acquisition.

• 2026 consolidated guidance: revenue ~$3.75B (up high teens), adjusted EBITDA $645–$660M (up low- to mid-teens), non-GAAP EPS $4.55–$4.70 (up mid- to high teens), and free cash flow $305M–$320M.

• 2025 financials: revenue $3.2B (up 18%), adjusted EBITDA $574M (up 15%), non-GAAP EPS $4.01 (up 20%), and free cash flow $295M.

• 4Q25 revenue up 19% year-over-year, driven by commercial operations; adjusted EBITDA up 13%.